Receptors of Eccrine, Apocrine, and Holocrine Skin Glands

Dermatologic Clinics

Volumn 25, Issue 4, 2007, Pages 577-588

  Wollina, Uwe ^a   Abdel Naser, Mohamed Badawy ^b   Ganceviciene, Ruta ^c,d   Zouboulis, Christos C ^c,e  

^a ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d VILNIUS UNIVERSITY   (Lithuania)

^e DESSAU MEDICAL CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CALCITONIN RECEPTOR LIKE RECEPTOR; CANNABINOID RECEPTOR; CYTOKINE RECEPTOR; ESTROGEN RECEPTOR; GLUCOCORTICOID; IMMUNOGLOBULIN E; MELANOCORTIN RECEPTOR; MINERALOCORTICOID; MUSCARINIC RECEPTOR; NEUROTROPHIC FACTOR; NICOTINIC RECEPTOR; RETINOID DERIVATIVE; REXINOID; SEX HORMONE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ACNE; ANHIDROSIS; APOCRINE GLAND; BODY TEMPERATURE; DNA SEQUENCE; HOLOCRINE GLAND; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; NONHUMAN; PAGET SKIN DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PRURITUS; PUSTULOSIS PALMOPLANTARIS; REVIEW; SEBACEOUS GLAND; SEBUM SECRETION; SKIN DISEASE; SKIN GLAND; SWEAT GLAND; URTICARIA;

HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, NEUROTRANSMITTER; RECEPTORS, STEROID; SEBACEOUS GLANDS; SKIN DISEASES; SWEAT GLANDS;

EID: 34648843005     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2007.06.001     Document Type: Review

References (100)

1. Loomis C.A., and Birge M.B. Fetal skin development. In: Eichenfield L.F., Frieden I.J., and Esterly N.B. (Eds). Textbook of neonatal dermatology (2001), WB Saunders, Philadelphia 1-17
2. Zouboulis C.C., Fimmel S., Ortmann J., et al. Sebaceous glands. In: Hoath S.B., and Maibach H.I. (Eds). Neonatal skin-structure and function. 2nd edition (2003), Marcel Dekker, New York 59-88
3. Thornton M.J. The biological actions of estrogens on skin. Exp Dermatol 11 (2002) 487-502
4. Vevrier-Sévrain S., Bonté F., and Gilchrest B. Biology of estrogens in skin: implications for aging skin. Exp Dermatol 15 (2006) 83-94
5. De Angelis M., Stossi F., Waibel M., et al. Isocoumarins as estrogen receptor beta selective ligands: isomers from isoflavone phytoestrogens and their metabolites. Bioorg Med Chem 23 (2005) 6529-6542
6. Makrantonaki E., Adjaye J., Herwig R., et al. Age-specific hormonal decline is accompanied by transcriptional changes in human sebocytes in vitro. Aging Cell 5 (2006) 331-344
7. Azzi L., El-Alfy M., and Labrie F. Gender differences and effects of sex steroids and dehydroepiandrosterone on androgen and oestrogen α receptors in mouse sebaceous glands. Br J Dermatol 154 (2006) 21-27
8. Thornton M.J., Taylor A.H., Mulligan K., et al. Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin. Exp Dermatol 12 (2003) 181-190
9. Kariya Y., Moriya T., Suzuki T., et al. Sex steroid hormone receptors in human skin appendage and its neoplasms. Endocr J 52 (2005) 317-325
10. Hu S., Bakshandeh H., Kerdel F.A., et al. Eccrine syringofibroadenoma of clear cell variant: an immunohistochemical study. Am J Dermatopathol 27 (2005) 228-231
11. Betis F., Hofman V., Lagier J., et al. Adénocarcinome sudoral primitive de la paupière de type eccrine à cellules en bague à chaton. J Fr Ophtalmol 25 (2002) 547-551
12. Mirza I., Kloss R., and Sieber S.C. Malignant eccrine spiradenoma. Arch Pathol Lab Med 126 (2002) 591-594
13. Beier K., Ginez I., and Schaller H. Localization of steroid hormone receptors in the apocrine sweat glands of the human axilla. Histochem Cell Biol 123 (2005) 61-65
14. Baulien E.-E., Thomas G., Legrain S., et al. Dehydroepiandrosterone (DHEA), DEHEA sulphate, and aging: contribution of the DHEAge study to a sociabiological issue. Proc Natl Acad Sci USA 97 (2000) 4279-4284
15. Labrie F., Lun-The V., Bélanger A., et al. Is dehydroepiandrosterone a hormone?. J Endocrinol 187 (2005) 169-196
16. Wallace M.L., and Smoller B.R. Progesterone receptor positivity supports hormonal control of syringomas. J Cutan Pathol 22 (1995) 442-445
17. Timpanidis P.C., Lakhani S.R., and Groves R.W. Progesterone receptor-positive syringoma associated with diabetes. J Am Acad Dermatol 48 Suppl 5 (2003) S103-S104
18. Fimmel S., Saborowski A., Térouanne B., et al. Inhibition of the androgen receptor by antisense oligonucleotides regulates the biological activity of androgens in SZ95 sebocytes. Horm Metab Res 39 (2007) 149-156
19. Choudhry R., Hodgins M.B., Van der Kwast T.H., et al. Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol 133 (1992) 467-475
20. Shikata N., Kurokawa I., Andachi H., et al. Expression of androgen receptors in skin appendage tumors: an immunohistochemical study. J Cutan Pathol 22 (1995) 149-153
21. Bratthauer G.L., Lininger R.A., Man Y.G., et al. Androgen and estrogen receptor mRNA status in apocrine carcinomas. Diagn Mol Pathol 11 (2002) 113-118
22. Hamilton K.S., Johnson S., and Smoller B.R. The role of androgen receptors in the clinical course of nevus sebaceous of Jadassohn. Mod Pathol 14 (2001) 539-542
23. Offidani A., and Campanati A. Papillary hidradenoma: immunohistochemical analysis of steroid receptor profile with a focus on apocrine differentiation. J Clin Pathol 52 (1999) 829-832
24. Stoeckelhuber M., Stoeckelhuber B.M., and Welsch U. Apocrine glands in the eyelid of primates contribute to the ocular host defense. Cells Tissues Organs 176 (2004) 187-194
25. Tamer C., Oksuz H., and Sohut S. Androgen status of the nonautoimmune dry eye. Ophthalmic Res 38 (2006) 280-286
26. Fujimoto A., Takata M., Hatta N., et al. Expression of structurally unaltered androgen receptor in extramammary Paget's disease. Lab Invest 80 (2000) 1465-1471
27. Diaz de Leon E., Carcangiu M.L., Prieto V.G., et al. Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor. Am J Clin Pathol 113 (2000) 572-575
28. Zouboulis C.C. Acne: sebaceous gland action. Clin Dermatol 22 (2004) 360-366
29. Huber J., and Walch K. Treating acne with oral contraceptives: use of lower doses. Contraception 73 (2006) 23-29
30. Katsabas A.D., Stefanaki C., and Cunliffe W.J. Guidelines for treating acne. Clin Dermatol 22 (2004) 439-444
31. Marynick S.P., Chakmakjian Z.H., McAffree D.L., et al. Androgen excess in cystic acne. N Engl J Med 308 (1983) 981-986
32. Shaw J.C. Acne: effect of hormones on pathogenesis and treatment. Am J Clin Dermatol 3 (2002) 571-578
33. Schröder U., Dries V., Klussmann J.P., et al. Successful adjuvant tamoxifen therapy for estrogen receptor-positive metastasizing sweat gland adenocarcinoma: need for a clinical trial?. Ann Otol Rhinol Laryngol 113 (2004) 242-244
34. Daniel S.J., Nader R., Kost K., et al. Facial sweat gland carcinoma metastasizing to neck nodes: a diagnostic and therapeutic challenge. Arch Otolaryngol Head Neck Surg 127 (2001) 1495-1498
35. Venencie P.Y., Méduri G., Pissard S., et al. Luteinizing hormone/human chorionic gonadotrophin receptors in various epidermal structures. Br J Dermatol 141 (1999) 438-446
36. Verrey F. Transcriptional control of sodium transport in tight epithelia by adrenal steroids. J Membr Biol 144 (1995) 93-110
37. Zennaro M.-C., Farman N., Bonvalet J.-P., et al. Tissue-specific expression of α and β messenger ribonucleic acid isoforms of the human mineralocorticoid receptor in normal and pathological states. J Clin Endocrinol Metab 82 (1997) 1345-1352
38. Hirasawa G., Sasano H., Takahasi K., et al. Colocalization of 11 beta-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human epithelia. J Clin Endocrinol Metab 82 (1997) 3859-3863
39. Nussey S., and Whitehead S. Endocrinology. An integrated approach (2001), BIOS Scientific Publisher, Oxford (UK)
40. Karstila T., Rechardt L., Honkaniemi J., et al. Immunocytochemical localization of glucocorticoid receptor in rat skin. Histochemistry 102 (1994) 305-309
41. Chen W., Yang C.-C., Sheu H.-M., et al. Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol 121 (2003) 441-447
42. Downie M.M., Sanders D.A., Maier L.M., et al. Peroxisome proliferation-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous glands cultures in vitro. Br J Dermatol 151 (2004) 766-775
43. 2 are active in sebaceous glands. J Mol Med 84 (2006) 75-87
44. Patel M.V., McKay I.A., and Burrin J.M. Transcriptional regulators of steroidogenesis, DAX-1 and SF-1, are expressed in human skin. J Invest Dermatol 117 (2001) 1559-1565
45. Chen W., Yang C., Liao C.Y., et al. Expression of sex-determining genes in human sebaceous glands and their possible roles in pathogenesis of acne. J Eur Acad Dermatol Venereol 20 (2006) 846-852
46. Trivedi N.R., Cong Z., Nelson A.M., et al. Peroxisome proliferator-activated receptors increase human sebum production. J Invest Dermatol 126 (2006) 2002-2009
47. Wróbel A., Seltmann H., Fimmel S., et al. Differentiation and apoptosis in human immortalized sebocytes. J Invest Dermatol 120 (2003) 175-181
48. Zhang Q., Seltmann H., Zouboulis C.C., et al. Involvement of PPARgamma in oxidative stress-mediated prostaglandin E(2) production in SZ95 human sebaceous gland cells. J Invest Dermatol 126 (2006) 42-48
49. Zouboulis C.C., Nestoris S., Adler Y.D., et al. A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor. Arch Dermatol 139 (2003) 668-670
50. Zouboulis C.C., Saborowski A., and Boschnakow A. Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production. Dermatology 210 (2005) 36-38
51. Misery L. Nicotine effects on skin: are they positive or negative?. Exp Dermatol 13 (2004) 665-670
52. Kim M.J., Deplewski D., Ciletti N., et al. Limited cooperation between peroxisome proliferators-activated receptors and retinoid X receptor antagonists in sebocyte growth and development. Mol Genet Metab 74 (2001) 362-369
53. Lippman S.M., and Lotan R. Advances in the development of retinoids as chemopreventive agents. J Nutr 130 (2000) 479S-482S
54. Yoshida T. Immunohistochemical localization of glial cell line-derived neurotrophic factor and its receptor Ret in the rat sweat gland. Kurume Med J 51 (2004) 193-202
55. Hiltunen P.H., and Airaksinen M.S. Sympathetic cholinergic target innervation requires GDNF family receptor GFR alpha 2. Mol Cell Neurosci 26 (2004) 450-457
56. Ständer S., Moormann C., Schumacher M., et al. Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures. Exp Dermatol 13 (2004) 129-139
57. Ständer S., Schmelz M., Metze D., et al. Distrubution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J Dermatol Sci 38 (2005) 177-188
58. Paus R., Schmelz M., Biro T., et al. Frontiers in pruritus research: scratching the brain. J Clin Invest 116 (2006) 1174-1186
59. Ikoma A., Steinhoff M., Ständer S., et al. The neurobiology of itch. Nat Rev Neurosci 7 (2006) 535-547
60. Grant M.P., and Landis S.C. Developmental expression of muscarinic cholinergic receptors and coupling to phospholipase C in rat sweat glands are independent of innervation. J Neurosci 11 (1991) 3772-3782
61. Landis S.C. Development of muscarinic receptors and regulation of secretory responsiveness in rodent sweat glands. Life Sci 64 (1999) 381-385
62. Haberberger R.V., and Bodenbenner M. Immunohistochemical localization of muscarinic receptors (M2) in the rat skin. Cell Tissue Res 300 (2000) 389-396
63. Schiavone A., and Brambilla A. Muscarinic M3 receptors mediate secretion from sweat glands in the rat. Pharmacol Res 23 (1991) 233-239
64. Golding J.F., and Stott J.R. Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion thickness, skin conductance and heart rate. Br J Clin Pharmacol 43 (1997) 633-637
65. Kurzen H., Berger H., Jäger C., et al. Phenotypical and molecular profiling of the extraneuronal cholinergic system of the skin. J Invest Dermatol 123 (2004) 937-949
66. Hagforsen E., Edvinsson M., Nordlind K., et al. Expression of nicotinic receptors in the skin of patients with palmoplantar pustulosis. Br J Dermatol 146 (2002) 383-391
67. Nakazato Y., Tamura N., Ohkuma A., et al. Idiopathic pure sudomotor failure: anhidrosis due to deficits in cholinergic transmission. Neurology 63 (2004) 1476-1480
68. Haider A., and Solish N. Focal hyperhidrosis: diagnosis and treatment. Can Med Assoc J 172 (2005) 69-75
69. Goldstein D.S., Pechnik S., Moak J., et al. Painful sweating. Neurology 63 (2004) 1471-1475
70. Takeda H., and Kondo S. Immunohistochemical study of angiotensin receptors in normal human sweat glands and eccrine poroma. Br J Dermatol 144 (2001) 1189-1192
71. Steckelings U.M., Wollschläger T., Peters J., et al. Human skin: source and target organ for angiotensin II. Exp Dermatol 13 (2004) 148-154
72. Millington G.W.M. Propiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors. Clin Exp Dermatol 31 (2006) 407-412
73. Böhm M., Schiller M., Ständer S., et al. Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in vivo. J Invest Dermatol 118 (2002) 533-539
74. Ständer S., Böhm M., Brzoska T., et al. Expression of melanocortin-1 receptor in normal, malformed and neoplastic skin glands and hair follicles. Exp Dermatol 11 (2002) 42-51
75. Zhang L., Li W.H., Anthonavage M., et al. Melanocortin-5 receptor: a marker of human sebocyte differentiation. Peptides 27 (2006) 413-420
76. Thiboutot D., Sivarajah A., Gilliand K., et al. The melanocortin 5 receptor is expressed in human sebaceous glands and rat preputial glands. J Invest Dermatol 115 (2000) 614-619
77. Gatting S.J. Targeting melanocortin receptors as potential novel therapeutics. Pharmacol Ther 111 (2006) 1-15
78. Kummer W., Herbst W.M., and Heym C. Vasoactive intestinal polypeptide receptor-like immunoreactivity in human sweat glands. Neurosci Lett 110 (1990) 239-243
79. Heinz-Erian P., Paul S., and Said S.I. Receptor for vasoactive intestinal peptide on isolated human sweat glands. Peptides 7 Suppl 1 (1986) 151-154
80. Wollina U., Bocker T., and Castelli E. Talgdrüsentumoren. In: Garbe C., Dummer R., Kaufmann R., et al. (Eds). Dermatologische Onkologie (1997), Springer-Verlag, Berlin 532-547
81. Wollina U., Paus R., and Feldrappe S. Sequential expression of glutathione-S-transferase isoenzymes during hair anagen growth in mice and their relationship to phosphotyrosinase and VIP receptor. Histol Histopathol 10 (1995) 39-45
82. Slominski A., Pisarchik A., Tobin D.J., et al. Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology 145 (2004) 941-950
83. Ganceviciene R, Marciukaitiene I, Graziene V, et al. New accents in the pathogenesis of acne vularis. Acta Medica, in press.
84. Zouboulis C.C., Seltmann H., Hiroi N., et al. Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci USA 99 (2002) 7148-7153
85. Krause K., Schnitger A., Fimmel S., et al. Corticotropin-releasing hormone skin signalling is receptor-mediated and is predominant in the sebaceous glands. Horm Metab Res 39 (2007) 166-170
86. Müller F.B., Müller-Rover S., Korge B.P., et al. Adrenomedullin: expression and possible role in human skin and hair growth. Br J Dermatol 148 (2003) 30-38
87. Deguchi M., Niwa M., Shigematsu K., et al. Specific [125I] Bolton-Hunter substance P binding sites in human and rat skin. Neurosci Lett 99 (1989) 287-292
88. Staniek V., Misery L., Peguet-Navarro J., et al. Expression of gastrin-releasing peptide receptor in human skin. Acta Derm Venereol 76 (1996) 282-286
89. Misery L., Bourchanny D., Kanitakis J., et al. Modulation of substance P and somatostatin receptors in cutaneous lymphocytic inflammatory and tumoral infiltrates. J Eur Acad Dermatol Venereol 15 (2001) 238-241
90. Krause S., Behrends J., Borowski A., et al. Blockade of interleukin-13-mediated cell activation by a novel inhibitory antibody to human IL-13 receptor alpha1. Mol Immunol 43 (2006) 1799-1807
91. Fichtner-Feigl S., Strober W., Kawakami K., et al. IL-13 signaling through the IL13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med 12 (2006) 99-106
92. Arima K., Sato K., Tanaka G., et al. Characterization of the interaction between interleukin-13 and interleukin-13 receptors. J Biol Chem 280 (2005) 24915-24922
93. Akaiwa M., Yu B., Umeshita-Suyama R., et al. Localization of human interleukin 13 receptor in non-haematopoietic cells. Cytokine 13 (2001) 75-84
94. Matsushita M., Yamamoto T., and Nishioka K. Upregulation of interleukin-13 and its receptor in a murine model of bleomycine-induce scleroderma. Int Arch Allergy Immunol 135 (2004) 348-356
95. Ahmed A.A., Nordlind K., Schultzberg M., et al. Proinflammatory cytokines and their corresponding receptor proteins in eccrine sweat glands in normal and cutaneous leishmaniasis human skin. An immunohistochemical study. Exp Dermatol 5 (1996) 230-235
96. Furue M., Kato M., Nakamura K., et al. Dysregulated expression of transforming growth factor beta and its type-I and type-II receptors in basal-cell carcinoma. Int J Cancer 71 (1997) 505-509
97. Wollina U., Lange D., Ten Dijke P., et al. Eccrine sweat glands: expression of transforming growth factor-beta and bone morphogenetic protein type I receptors and their intracellular Smad proteins. Acta Derm Venereol 79 (1999) 183-186
98. Wollina U., Lange D., Funa K., et al. Expression of transforming growth factor beta isoforms and their receptors during hair growth phases in mice. Histol Histopathol 11 (1996) 431-436
99. Zouboulis C.C. Human skin: an independent peripheral endocrine organ. Horm Res 54 (2000) 230-242
100. Zouboulis C.C. The human skin as a hormone target and an endocrine gland. Hormones 3 (2004) 9-26